Navigation
Excelsio Media by Nelson Alarcón - alarcónnelson

FDA panel narrowly backs Merck's at-home COVID-19 pill

FDA panel narrowly backs Merck's at-home COVID-19 pill
A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co's antiviral pill to treat COVID-19.


Share

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

Post A Comment:

0 comments:

Leave a comment. Thanks!